December 6, 2025 • 13 mins
This episode maps bipolar disorder with clear definitions of mania, hypomania, and depression—cutting through confusion to show how careful diagnosis prevents harmful treatment and opens the door to real, lasting stability. We translate clinical language into practical insight while addressing the stigma and loss of insight that often keep people from getting the help they need.
We begin by defining mania, hypomania, and major depression, then explore rapid cycling and mixed states, two complex presentations that can obscure a correct diagnosis. We outline the spectrum—Bipolar I, Bipolar II, and cyclothymia—and discuss prevalence, genetic influences, and the high rate of substance-use comorbidity. Because there’s no blood test for bipolar disorder, we explain why diagnosis depends on a lifetime history of mood episodes, not a single moment.
We then cover treatment essentials: the risks of antidepressants without a mood stabilizer, the roles and tradeoffs of lithium, valproate, and lamotrigine, and how antipsychotics can help while also posing metabolic side effects. We highlight the importance of psychotherapy, family education, relapse-prevention planning, and early intervention. Stigma and impaired insight remain the biggest barriers—and this episode provides tools for navigating both.
High-volume keywords used: bipolar disorder, mania, hypomania, mood stabilizer, lithium, diagnosis, depression, mental health treatment
Listener Takeaways
- Clear definitions of mania, hypomania, depression, and mixed states
- How Bipolar I, II, and cyclothymia fit on a diagnostic spectrum
- Why antidepressants alone can worsen bipolar symptoms
- The roles and tradeoffs of lithium, valproate, and lamotrigine
- How insight, stigma, and early intervention shape long-term stability
Follow for daily longevity and wellness episodes.
This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice.
Never miss an episode—subscribe on your favorite podcast app!
Mark as Played
Transcript
Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
SPEAKER_01 (00:00):
Welcome back to the deep dive.
So today we're jumping straightinto one of the most clinically
complex and I think oftenmisunderstood areas of mental
health (00:08):
bipolar disorder.
And if you're listening and youneed a really clear, actionable
guide to what we currentlyunderstand about it, what it is,
how it's diagnosed, how it'streated, well, we've got the
map.
SPEAKER_00 (00:20):
We do.
And we're using some high-gradematerials for this mission.
We're mostly synthesizing areally comprehensive review from
Harvard Health Publishing.
And the goal here is to get pastthe, you know, that simple idea
of just mood swings.
Right.
We want to explain why thiscondition, which uh used to be
called manic depression, isreally a spectrum disorder and
why that distinction is soimportant.
SPEAKER_01 (00:41):
Okay, so let's start at the very beginning.
At its most basic, bipolardisorder is about these wide
swings in mood, right?
Cycling between a high statemania and a low state
depression.
Right.
SPEAKER_00 (00:51):
But we have to be so clear here.
Yeah.
We aren't just talking about arocky week at work.
These are sustained, episodic,and often, you know, totally
debilitating shifts.
SPEAKER_01 (01:01):
Aaron Powell They're fundamental state changes, not
just a shift in temperament.
Trevor Burrus, Jr.
SPEAKER_00 (01:05):
That's the essential insight, yes.
It's something that alters aperson's entire behavior, their
energy, their relationship withreality itself.
SPEAKER_01 (01:12):
Aaron Powell So let's unpack that high pole
first, the Matic episode.
The sources describe it as thestate of being, well,
hyperactive, but usually in areally scattered and
unproductive way.
SPEAKER_00 (01:24):
Totally unproductive.
SPEAKER_01 (01:25):
The person is just full of what seems like
boundless energy.
They can be very irritable, theyfeel a little need for sleep,
and they might start developingthese grand, elaborate, and
completely impossible plans.
SPEAKER_00 (01:37):
Aaron Powell And that's where the risk comes in.
That's the really dangerous partof it.
Because while the person mightfeel euphoric, their judgment,
their executive function, it'sjust gone.
SPEAKER_01 (01:46):
So the consequences can be huge.
SPEAKER_00 (01:48):
Huge.
And incredibly damaging.
The source material detailsthese actions that, well, they
lead to immense pain andembarrassment later.
Things like spending way moremoney than they have, or uh
engaging in sexual adventuresthey deeply regret, or even
running into trouble with thelaw.
SPEAKER_01 (02:04):
Because of that recklessness.
SPEAKER_00 (02:06):
That complete lack of impulse control.
SPEAKER_01 (02:08):
Yeah.
And you mentioned something keythere, the loss of judgment.
When someone is in that state,they genuinely believe their
grand plans are not justrealistic, but brilliant.
SPEAKER_00 (02:17):
Aaron Powell Precisely.
Which brings us to a reallycritical distinction between the
two types of highs.
Because if the symptoms aremilder, you know, the person's
energetic, maybe evenproductive, but they don't lose
touch with reality, we call thata hypomanic episode.
SPEAKER_01 (02:32):
Aaron Powell Hypomania.
So the key difference isseverity and I guess the
presence of psychosis.
SPEAKER_00 (02:38):
Aaron Powell It is, exactly.
Full mania is much, much moresevere, and it can often include
psychotic symptoms.
So for instance, during thatgrandiose phase, they might
genuinely believe they havespecial powers, delusions of
grandeur.
Or if the mania is moreirritable, they can become
deeply paranoid and suspicious.
SPEAKER_01 (02:54):
And hypomania doesn't cross that line.
SPEAKER_00 (02:56):
Aaron Powell By definition, no.
It does not cross that line intopsychosis.
SPEAKER_01 (02:59):
Aaron Powell Okay.
So if the manic pull is aboutthis recklessness, the sources
make it very clear that thedepressive pull is, for the
patient, often the most common,the most distressing, and the
most dangerous part of theillness.
SPEAKER_00 (03:12):
Aaron Powell Absolutely.
The depressive phase is wherethe illness just extracts this
terrible toll.
It tends to last longer.
And because of the, you know,the significantly higher risk of
suicide, it requires the mostintense vigilance from everyone.
SPEAKER_01 (03:26):
Aaron Powell We're talking about symptoms that just
crush the spirit, a distinctlylow, sometimes intensely
irritable mood, a deep loss ofinterest or pleasure in well, in
in everything.
SPEAKER_00 (03:36):
Aaron Powell That's called anhedonia.
It's a core symptom.
SPEAKER_01 (03:39):
Aaron Powell Right.
And then you see these majorchanges in basic functions
eating, sleeping, weight,intense feelings of
worthlessness, guilt, poorconcentration, and terrifyingly
frequent thoughts of death orsuicide.
SPEAKER_00 (03:50):
Aaron Powell And just when you think you've sort
of mapped out the two poles, itgets more complicated.
SPEAKER_01 (03:54):
It's not always a clean switch.
SPEAKER_00 (03:56):
Not at all.
The source material mentionsrapid cycling, where a patient
switches back and forthfrequently within a year.
Yeah.
And even more confusing, mixedepisodes where symptoms of mania
and depression are happening atthe same time.
SPEAKER_01 (04:07):
Aaron Powell That sounds absolutely agonizing.
To be agitated and full of manicenergy, but at the same time
feel desperately suicidal.
SPEAKER_00 (04:14):
It's incredibly challenging to treat because the
strategies for depression andmania can be, well,
contradictory.
It really just highlights thatwe're dealing with a complex
brain state.
SPEAKER_01 (04:24):
Aaron Powell Okay, so let's use these definitions:
mania, hypomania, depression, tomap out the clinical spectrum.
Researchers seem to categorizethis into three main types.
SPEAKER_00 (04:35):
Aaron Powell Yes.
And these classifications arevital.
They really determine how theillness is managed long term.
SPEAKER_01 (04:40):
Aaron Powell So we start with bipolar eye disorder.
This is the classic form, themost severe.
And the diagnostic requirementis simple.
The person has to have had atleast one full manic episode.
That's it.
SPEAKER_00 (04:51):
The defining anchor is that full-blown mania.
Depressive episodes are usuallythere too, and they're awful.
But it's the mania that definesbipolar one.
SPEAKER_01 (04:59):
Aaron Powell Then you have bipolar two disorder.
Now, this is often mistaken forjust major depressive disorders
because the depression is soprominent.
SPEAKER_00 (05:05):
It really is.
SPEAKER_01 (05:06):
But bipolar two is defined by having at least one
hypomanic episode, the milderone we talked about, and at
least one major depressiveepisode.
And the critical thing is that aperson with bipolar two has
never had a full manic episode.
SPEAKER_00 (05:19):
That is the single most important differentiating
marker.
So if someone comes in withsevere depression, the doctor
has to ask about their history.
Have you ever had a period ofunusual energy where you didn't
need to sleep?
That's the key.
SPEAKER_01 (05:31):
And the third one is cyclothemia.
SPEAKER_00 (05:33):
Yes.
A persistent but milder form.
The person is always fluctuatingbetween hypomanic symptoms and
mild or moderate depression.
It's this chronic moodinstability, but it never hits
the severity to qualify as afull manic or full depressive
episode.
SPEAKER_01 (05:50):
Aaron Powell It's like the storm is always on the
horizon, but never fully makeslandfall.
SPEAKER_00 (05:55):
A good way to put it, yes.
SPEAKER_01 (05:56):
Aaron Powell Looking at the bigger picture then, what
about prevalence?
Is there anything surprisingthere?
SPEAKER_00 (05:59):
Aaron Powell There is, actually.
Unlike major depression, wherewomen are diagnosed far more
often, bipolar disorder occursnearly equally in men and women.
SPEAKER_01 (06:07):
Aaron Powell Really?
That's that's a key fact.
SPEAKER_00 (06:09):
Aaron Powell It is.
And the estimates put it at upto maybe 4% of the population,
if you include the milder forms.
But the risks are the big storyhere.
It tends to run very heavily infamilies, so there's a strong
genetic link.
And the most alarming risks are,as we said, the very high rate
of suicide and a much higherlikelihood of struggling with
alcohol or substance use.
SPEAKER_01 (06:30):
Aaron Powell, which makes a kind of heartbreaking
sense trying to self-medicatethose terrifying mood swings.
SPEAKER_00 (06:34):
Aaron Powell Exactly.
It creates a really dangerouscycle that makes diagnosis and
treatment that much harder.
SPEAKER_01 (06:39):
Okay, so let's move into that diagnostic process.
I'll tell you the sources arereally explicit here.
SPEAKER_00 (06:44):
Yeah.
SPEAKER_01 (06:44):
There are no medical tests, no blood draw, no brain
span.
SPEAKER_00 (06:48):
Correct.
The diagnosis relies completelyon a mental health professional
gathering a person's history, athorough, detailed history of
their symptoms over their entirelifetime, not just how they feel
today.
SPEAKER_01 (07:00):
And this brings us to what I think is maybe the
most vital takeaway from thiswhole deep dive: the treatment
trigger.
People are much more likely toseek help when they're
depressed, right?
Not when they're manic and feelinvincible.
SPEAKER_00 (07:12):
Of course.
And this is where clinicalprecision can be literally
life-saving.
Because if a doctor only seesthe depression and they
prescribe an antidepressantalone to a person who actually
has an undiagnosed bipolarhistory.
SPEAKER_01 (07:26):
That antidepressant can act like jet fuel.
SPEAKER_00 (07:28):
It can.
It can trigger a full, severemanic episode.
It can be catastrophic.
SPEAKER_01 (07:34):
So taking that history, asking about those past
periods of high energy orrecklessness, it's not just a
formality.
It's a critical safety measure.
SPEAKER_00 (07:42):
It is absolutely essential.
SPEAKER_01 (07:43):
And what happens if the illness is just left
untreated?
SPEAKER_00 (07:47):
Well, the sources say an untreated manic episode
lasts about two to four months,and a depressive episode can go
on for eight months or evenlonger.
SPEAKER_01 (07:54):
And it gets worse over time, doesn't it?
SPEAKER_00 (07:56):
It does.
Without treatment, the episodestend to become more frequent and
last longer.
The illness has a progressivequality if it's not managed.
SPEAKER_01 (08:04):
Aaron Powell, which just reinforces the urgency of
getting a proper diagnosis andtreatment plan.
SPEAKER_00 (08:08):
It does.
So let's shift to thosetreatment strategies.
The emphasis is always on acombination approach.
SPEAKER_01 (08:13):
Aaron Powell Right.
It's almost never just onething.
It's medication and talk therapyor psychotherapy working
together.
And often it's more than onemedication.
SPEAKER_00 (08:22):
Aaron Powell Correct.
And on the medication front, thefoundation is mood stabilizers.
SPEAKER_01 (08:25):
Trevor Burrus And the best known, the oldest, the
one with the longest trackrecord, is lithium.
SPEAKER_00 (08:30):
Lithium is still considered a gold standard by
many.
Its efficacy is profound.
It reduces acute mania.
It's excellent at preventingfuture episodes.
And crucially, some studiessuggest it reduces the overall
risk of suicide.
SPEAKER_01 (08:43):
Aaron Powell But it's a commitment to take it.
It requires regular blood teststo check the levels, and it has
side effects like nausea,tremor, sometimes a kind of
diminished mental sharpness.
SPEAKER_00 (08:53):
Aaron Powell That cognitive fuzziness, yeah.
And because of that, doctorsoften turn to other mood
stabilizers, specificallyanti-seizure medications.
The two big ones cited in oursources are valproic acid, or
depict, and lamatrogeny, orlamictal.
SPEAKER_01 (09:09):
And they serve different purposes, don't they?
SPEAKER_00 (09:11):
They do.
Valproic acid is good for mania,but it has rare risks like liver
damage, and it's well known forcausing weight gain.
Limotrogen, on the other hand,is particularly good at
preventing the depressiveepisodes, but it's less
effective than lithium forpreventing mania.
SPEAKER_01 (09:31):
A severe rash.
SPEAKER_00 (09:32):
It does.
Which is why doctors minimizethat risk by starting the dose
extremely low and increasing itvery, very slowly, a process
called titration.
SPEAKER_01 (09:41):
And we have to pause here for a really critical point
about pregnancy.
SPEAKER_00 (09:44):
Yes.
The sources are very clear.
Both lithium and valproic acidcarry risks of birth defects,
especially in the firsttrimester.
So any woman consideringpregnancy needs to have a very
detailed, careful discussionwith her doctor about the risks
and benefits.
SPEAKER_01 (09:58):
That really brings us back to that controversial
topic we touched onantidepressants.
SPEAKER_00 (10:03):
Right.
The controversy is all aboutthat trigger risk.
An antidepressant on its own canpush someone into mania or rapid
cycling.
So they're almost never used asthe only treatment.
If they are used, it's verycarefully and always alongside a
mood stabilizer or anantipsychotic.
SPEAKER_01 (10:18):
Like a guardrail.
SPEAKER_00 (10:18):
Exactly.
A chemical guardrail.
SPEAKER_01 (10:20):
And that leads us to that other class of medications.
Yeah.
Antipsychotics.
The newer ones are used a lot,not just for psychosis, but for
symptom control across theboard.
SPEAKER_00 (10:28):
They're very effective.
But this is where the art ofmedicine really comes in.
It becomes a balancing actbetween controlling symptoms and
managing side effects.
Many of these drugs can increasethe risk of diabetes and high
cholesterol.
SPEAKER_01 (10:41):
The sources draw a clear line here, for instance.
Olenzepine has the highest riskfor weight gain and metabolic
issues.
But drugs like ziprasidone andare epiprazole cause minimal
weight change.
So there are choices.
SPEAKER_00 (10:54):
There are choices, and the physician has to tailor
the medication to the patient'swhole health profile, which is
why the final pillarpsychotherapy, talk therapy, is
just non-negotiable.
SPEAKER_01 (11:04):
Right.
The meds stabilize the brainchemistry, but therapy helps the
person live with the illness.
What's its specific role?
SPEAKER_00 (11:10):
Oh, it's incredibly broad.
Therapy provides essentialeducation and support for the
patient and their family.
It teaches them to recognizethose early warning signs, the
first hints of hypomania ordepression, so they can
intervene early.
SPEAKER_01 (11:24):
And I imagine it's also crucial for dealing with
the fallout from past episodes.
SPEAKER_00 (11:28):
Absolutely.
Helping the person deal with thepainful, often embarrassing
consequences of past manicbehavior, repairing
relationships, managingfinancial damage, and the
sources are emphatic that whenthe family gets educated and
involved, patient outcomes areso much better.
Fewer episodes, fewer hospitalstays.
SPEAKER_01 (11:47):
It's a systemic illness that requires a holistic
approach.
So as we wrap up, let's distillthe key takeaways for you, the
listener.
First, bipolar disorder is aspectrum.
Eye, eye, and cyclemia, alldefined by the severity of the
highs.
And second, that diagnosticprocess is life-saving.
A meticulous history is neededto avoid triggering mania with
the wrong prescription.
SPEAKER_00 (12:07):
And we really have to reiterate that social context
from the Harvard material.
Stigma is a silent killer.
People worry about the label, sothey don't discuss those milder
symptoms of mood instabilitywith their doctor.
But that early intervention isexactly how you can head off a
more severe form of the disorderdown the line.
SPEAKER_01 (12:25):
And the ultimate message from the sources is
really one of persistence andhope.
Finding the right medicationcocktail can take time, yes, but
the prognosis is overwhelminglyencouraging.
Treatment can be highlyeffective.
Often it diminishes or eveneliminates symptoms, allowing
people to lead completelynormal, successful lives.
SPEAKER_00 (12:44):
It's a profound message of resilience and
clinical progress.
SPEAKER_01 (12:47):
Which leaves us with one final thought for you to
chew on today.
Given that treatment is soeffective, what single factor do
you think presents the mostdifficult hurdle to achieving
that positive, stable prognosis?
Think about that challengingduality, the societal stigma
that prevents the firstconversation, compounded by the
patient's own lack of insightwhen they're in the throes of
mania.
(13:07):
We'll see you next time on TheDeep Dive.
Welcome back to the deep dive.
So today we're jumping straightinto one of the most clinically
complex and I think oftenmisunderstood areas of mental
health (00:08):
bipolar disorder.
And if you're listening and youneed a really clear, actionable
guide to what we currentlyunderstand about it, what it is,
how it's diagnosed, how it'streated, well, we've got the
map.
SPEAKER_00 (00:20):
We do.
And we're using some high-gradematerials for this mission.
We're mostly synthesizing areally comprehensive review from
Harvard Health Publishing.
And the goal here is to get pastthe, you know, that simple idea
of just mood swings.
Right.
We want to explain why thiscondition, which uh used to be
called manic depression, isreally a spectrum disorder and
why that distinction is soimportant.
SPEAKER_01 (00:41):
Okay, so let's start at the very beginning.
At its most basic, bipolardisorder is about these wide
swings in mood, right?
Cycling between a high statemania and a low state
depression.
Right.
SPEAKER_00 (00:51):
But we have to be so clear here.
Yeah.
We aren't just talking about arocky week at work.
These are sustained, episodic,and often, you know, totally
debilitating shifts.
SPEAKER_01 (01:01):
Aaron Powell They're fundamental state changes, not
just a shift in temperament.
Trevor Burrus, Jr.
SPEAKER_00 (01:05):
That's the essential insight, yes.
It's something that alters aperson's entire behavior, their
energy, their relationship withreality itself.
SPEAKER_01 (01:12):
Aaron Powell So let's unpack that high pole
first, the Matic episode.
The sources describe it as thestate of being, well,
hyperactive, but usually in areally scattered and
unproductive way.
SPEAKER_00 (01:24):
Totally unproductive.
SPEAKER_01 (01:25):
The person is just full of what seems like
boundless energy.
They can be very irritable, theyfeel a little need for sleep,
and they might start developingthese grand, elaborate, and
completely impossible plans.
SPEAKER_00 (01:37):
Aaron Powell And that's where the risk comes in.
That's the really dangerous partof it.
Because while the person mightfeel euphoric, their judgment,
their executive function, it'sjust gone.
SPEAKER_01 (01:46):
So the consequences can be huge.
SPEAKER_00 (01:48):
Huge.
And incredibly damaging.
The source material detailsthese actions that, well, they
lead to immense pain andembarrassment later.
Things like spending way moremoney than they have, or uh
engaging in sexual adventuresthey deeply regret, or even
running into trouble with thelaw.
SPEAKER_01 (02:04):
Because of that recklessness.
SPEAKER_00 (02:06):
That complete lack of impulse control.
SPEAKER_01 (02:08):
Yeah.
And you mentioned something keythere, the loss of judgment.
When someone is in that state,they genuinely believe their
grand plans are not justrealistic, but brilliant.
SPEAKER_00 (02:17):
Aaron Powell Precisely.
Which brings us to a reallycritical distinction between the
two types of highs.
Because if the symptoms aremilder, you know, the person's
energetic, maybe evenproductive, but they don't lose
touch with reality, we call thata hypomanic episode.
SPEAKER_01 (02:32):
Aaron Powell Hypomania.
So the key difference isseverity and I guess the
presence of psychosis.
SPEAKER_00 (02:38):
Aaron Powell It is, exactly.
Full mania is much, much moresevere, and it can often include
psychotic symptoms.
So for instance, during thatgrandiose phase, they might
genuinely believe they havespecial powers, delusions of
grandeur.
Or if the mania is moreirritable, they can become
deeply paranoid and suspicious.
SPEAKER_01 (02:54):
And hypomania doesn't cross that line.
SPEAKER_00 (02:56):
Aaron Powell By definition, no.
It does not cross that line intopsychosis.
SPEAKER_01 (02:59):
Aaron Powell Okay.
So if the manic pull is aboutthis recklessness, the sources
make it very clear that thedepressive pull is, for the
patient, often the most common,the most distressing, and the
most dangerous part of theillness.
SPEAKER_00 (03:12):
Aaron Powell Absolutely.
The depressive phase is wherethe illness just extracts this
terrible toll.
It tends to last longer.
And because of the, you know,the significantly higher risk of
suicide, it requires the mostintense vigilance from everyone.
SPEAKER_01 (03:26):
Aaron Powell We're talking about symptoms that just
crush the spirit, a distinctlylow, sometimes intensely
irritable mood, a deep loss ofinterest or pleasure in well, in
in everything.
SPEAKER_00 (03:36):
Aaron Powell That's called anhedonia.
It's a core symptom.
SPEAKER_01 (03:39):
Aaron Powell Right.
And then you see these majorchanges in basic functions
eating, sleeping, weight,intense feelings of
worthlessness, guilt, poorconcentration, and terrifyingly
frequent thoughts of death orsuicide.
SPEAKER_00 (03:50):
Aaron Powell And just when you think you've sort
of mapped out the two poles, itgets more complicated.
SPEAKER_01 (03:54):
It's not always a clean switch.
SPEAKER_00 (03:56):
Not at all.
The source material mentionsrapid cycling, where a patient
switches back and forthfrequently within a year.
Yeah.
And even more confusing, mixedepisodes where symptoms of mania
and depression are happening atthe same time.
SPEAKER_01 (04:07):
Aaron Powell That sounds absolutely agonizing.
To be agitated and full of manicenergy, but at the same time
feel desperately suicidal.
SPEAKER_00 (04:14):
It's incredibly challenging to treat because the
strategies for depression andmania can be, well,
contradictory.
It really just highlights thatwe're dealing with a complex
brain state.
SPEAKER_01 (04:24):
Aaron Powell Okay, so let's use these definitions:
mania, hypomania, depression, tomap out the clinical spectrum.
Researchers seem to categorizethis into three main types.
SPEAKER_00 (04:35):
Aaron Powell Yes.
And these classifications arevital.
They really determine how theillness is managed long term.
SPEAKER_01 (04:40):
Aaron Powell So we start with bipolar eye disorder.
This is the classic form, themost severe.
And the diagnostic requirementis simple.
The person has to have had atleast one full manic episode.
That's it.
SPEAKER_00 (04:51):
The defining anchor is that full-blown mania.
Depressive episodes are usuallythere too, and they're awful.
But it's the mania that definesbipolar one.
SPEAKER_01 (04:59):
Aaron Powell Then you have bipolar two disorder.
Now, this is often mistaken forjust major depressive disorders
because the depression is soprominent.
SPEAKER_00 (05:05):
It really is.
SPEAKER_01 (05:06):
But bipolar two is defined by having at least one
hypomanic episode, the milderone we talked about, and at
least one major depressiveepisode.
And the critical thing is that aperson with bipolar two has
never had a full manic episode.
SPEAKER_00 (05:19):
That is the single most important differentiating
marker.
So if someone comes in withsevere depression, the doctor
has to ask about their history.
Have you ever had a period ofunusual energy where you didn't
need to sleep?
That's the key.
SPEAKER_01 (05:31):
And the third one is cyclothemia.
SPEAKER_00 (05:33):
Yes.
A persistent but milder form.
The person is always fluctuatingbetween hypomanic symptoms and
mild or moderate depression.
It's this chronic moodinstability, but it never hits
the severity to qualify as afull manic or full depressive
episode.
SPEAKER_01 (05:50):
Aaron Powell It's like the storm is always on the
horizon, but never fully makeslandfall.
SPEAKER_00 (05:55):
A good way to put it, yes.
SPEAKER_01 (05:56):
Aaron Powell Looking at the bigger picture then, what
about prevalence?
Is there anything surprisingthere?
SPEAKER_00 (05:59):
Aaron Powell There is, actually.
Unlike major depression, wherewomen are diagnosed far more
often, bipolar disorder occursnearly equally in men and women.
SPEAKER_01 (06:07):
Aaron Powell Really?
That's that's a key fact.
SPEAKER_00 (06:09):
Aaron Powell It is.
And the estimates put it at upto maybe 4% of the population,
if you include the milder forms.
But the risks are the big storyhere.
It tends to run very heavily infamilies, so there's a strong
genetic link.
And the most alarming risks are,as we said, the very high rate
of suicide and a much higherlikelihood of struggling with
alcohol or substance use.
SPEAKER_01 (06:30):
Aaron Powell, which makes a kind of heartbreaking
sense trying to self-medicatethose terrifying mood swings.
SPEAKER_00 (06:34):
Aaron Powell Exactly.
It creates a really dangerouscycle that makes diagnosis and
treatment that much harder.
SPEAKER_01 (06:39):
Okay, so let's move into that diagnostic process.
I'll tell you the sources arereally explicit here.
SPEAKER_00 (06:44):
Yeah.
SPEAKER_01 (06:44):
There are no medical tests, no blood draw, no brain
span.
SPEAKER_00 (06:48):
Correct.
The diagnosis relies completelyon a mental health professional
gathering a person's history, athorough, detailed history of
their symptoms over their entirelifetime, not just how they feel
today.
SPEAKER_01 (07:00):
And this brings us to what I think is maybe the
most vital takeaway from thiswhole deep dive: the treatment
trigger.
People are much more likely toseek help when they're
depressed, right?
Not when they're manic and feelinvincible.
SPEAKER_00 (07:12):
Of course.
And this is where clinicalprecision can be literally
life-saving.
Because if a doctor only seesthe depression and they
prescribe an antidepressantalone to a person who actually
has an undiagnosed bipolarhistory.
SPEAKER_01 (07:26):
That antidepressant can act like jet fuel.
SPEAKER_00 (07:28):
It can.
It can trigger a full, severemanic episode.
It can be catastrophic.
SPEAKER_01 (07:34):
So taking that history, asking about those past
periods of high energy orrecklessness, it's not just a
formality.
It's a critical safety measure.
SPEAKER_00 (07:42):
It is absolutely essential.
SPEAKER_01 (07:43):
And what happens if the illness is just left
untreated?
SPEAKER_00 (07:47):
Well, the sources say an untreated manic episode
lasts about two to four months,and a depressive episode can go
on for eight months or evenlonger.
SPEAKER_01 (07:54):
And it gets worse over time, doesn't it?
SPEAKER_00 (07:56):
It does.
Without treatment, the episodestend to become more frequent and
last longer.
The illness has a progressivequality if it's not managed.
SPEAKER_01 (08:04):
Aaron Powell, which just reinforces the urgency of
getting a proper diagnosis andtreatment plan.
SPEAKER_00 (08:08):
It does.
So let's shift to thosetreatment strategies.
The emphasis is always on acombination approach.
SPEAKER_01 (08:13):
Aaron Powell Right.
It's almost never just onething.
It's medication and talk therapyor psychotherapy working
together.
And often it's more than onemedication.
SPEAKER_00 (08:22):
Aaron Powell Correct.
And on the medication front, thefoundation is mood stabilizers.
SPEAKER_01 (08:25):
Trevor Burrus And the best known, the oldest, the
one with the longest trackrecord, is lithium.
SPEAKER_00 (08:30):
Lithium is still considered a gold standard by
many.
Its efficacy is profound.
It reduces acute mania.
It's excellent at preventingfuture episodes.
And crucially, some studiessuggest it reduces the overall
risk of suicide.
SPEAKER_01 (08:43):
Aaron Powell But it's a commitment to take it.
It requires regular blood teststo check the levels, and it has
side effects like nausea,tremor, sometimes a kind of
diminished mental sharpness.
SPEAKER_00 (08:53):
Aaron Powell That cognitive fuzziness, yeah.
And because of that, doctorsoften turn to other mood
stabilizers, specificallyanti-seizure medications.
The two big ones cited in oursources are valproic acid, or
depict, and lamatrogeny, orlamictal.
SPEAKER_01 (09:09):
And they serve different purposes, don't they?
SPEAKER_00 (09:11):
They do.
Valproic acid is good for mania,but it has rare risks like liver
damage, and it's well known forcausing weight gain.
Limotrogen, on the other hand,is particularly good at
preventing the depressiveepisodes, but it's less
effective than lithium forpreventing mania.
SPEAKER_01 (09:31):
A severe rash.
SPEAKER_00 (09:32):
It does.
Which is why doctors minimizethat risk by starting the dose
extremely low and increasing itvery, very slowly, a process
called titration.
SPEAKER_01 (09:41):
And we have to pause here for a really critical point
about pregnancy.
SPEAKER_00 (09:44):
Yes.
The sources are very clear.
Both lithium and valproic acidcarry risks of birth defects,
especially in the firsttrimester.
So any woman consideringpregnancy needs to have a very
detailed, careful discussionwith her doctor about the risks
and benefits.
SPEAKER_01 (09:58):
That really brings us back to that controversial
topic we touched onantidepressants.
SPEAKER_00 (10:03):
Right.
The controversy is all aboutthat trigger risk.
An antidepressant on its own canpush someone into mania or rapid
cycling.
So they're almost never used asthe only treatment.
If they are used, it's verycarefully and always alongside a
mood stabilizer or anantipsychotic.
SPEAKER_01 (10:18):
Like a guardrail.
SPEAKER_00 (10:18):
Exactly.
A chemical guardrail.
SPEAKER_01 (10:20):
And that leads us to that other class of medications.
Yeah.
Antipsychotics.
The newer ones are used a lot,not just for psychosis, but for
symptom control across theboard.
SPEAKER_00 (10:28):
They're very effective.
But this is where the art ofmedicine really comes in.
It becomes a balancing actbetween controlling symptoms and
managing side effects.
Many of these drugs can increasethe risk of diabetes and high
cholesterol.
SPEAKER_01 (10:41):
The sources draw a clear line here, for instance.
Olenzepine has the highest riskfor weight gain and metabolic
issues.
But drugs like ziprasidone andare epiprazole cause minimal
weight change.
So there are choices.
SPEAKER_00 (10:54):
There are choices, and the physician has to tailor
the medication to the patient'swhole health profile, which is
why the final pillarpsychotherapy, talk therapy, is
just non-negotiable.
SPEAKER_01 (11:04):
Right.
The meds stabilize the brainchemistry, but therapy helps the
person live with the illness.
What's its specific role?
SPEAKER_00 (11:10):
Oh, it's incredibly broad.
Therapy provides essentialeducation and support for the
patient and their family.
It teaches them to recognizethose early warning signs, the
first hints of hypomania ordepression, so they can
intervene early.
SPEAKER_01 (11:24):
And I imagine it's also crucial for dealing with
the fallout from past episodes.
SPEAKER_00 (11:28):
Absolutely.
Helping the person deal with thepainful, often embarrassing
consequences of past manicbehavior, repairing
relationships, managingfinancial damage, and the
sources are emphatic that whenthe family gets educated and
involved, patient outcomes areso much better.
Fewer episodes, fewer hospitalstays.
SPEAKER_01 (11:47):
It's a systemic illness that requires a holistic
approach.
So as we wrap up, let's distillthe key takeaways for you, the
listener.
First, bipolar disorder is aspectrum.
Eye, eye, and cyclemia, alldefined by the severity of the
highs.
And second, that diagnosticprocess is life-saving.
A meticulous history is neededto avoid triggering mania with
the wrong prescription.
SPEAKER_00 (12:07):
And we really have to reiterate that social context
from the Harvard material.
Stigma is a silent killer.
People worry about the label, sothey don't discuss those milder
symptoms of mood instabilitywith their doctor.
But that early intervention isexactly how you can head off a
more severe form of the disorderdown the line.
SPEAKER_01 (12:25):
And the ultimate message from the sources is
really one of persistence andhope.
Finding the right medicationcocktail can take time, yes, but
the prognosis is overwhelminglyencouraging.
Treatment can be highlyeffective.
Often it diminishes or eveneliminates symptoms, allowing
people to lead completelynormal, successful lives.
SPEAKER_00 (12:44):
It's a profound message of resilience and
clinical progress.
SPEAKER_01 (12:47):
Which leaves us with one final thought for you to
chew on today.
Given that treatment is soeffective, what single factor do
you think presents the mostdifficult hurdle to achieving
that positive, stable prognosis?
Think about that challengingduality, the societal stigma
that prevents the firstconversation, compounded by the
patient's own lack of insightwhen they're in the throes of
mania.
(13:07):
We'll see you next time on TheDeep Dive.
Popular Podcasts
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
My Favorite Murder with Karen Kilgariff and Georgia Hardstark
My Favorite Murder is a true crime comedy podcast hosted by Karen Kilgariff and Georgia Hardstark. Each week, Karen and Georgia share compelling true crimes and hometown stories from friends and listeners. Since MFM launched in January of 2016, Karen and Georgia have shared their lifelong interest in true crime and have covered stories of infamous serial killers like the Night Stalker, mysterious cold cases, captivating cults, incredible survivor stories and important events from history like the Tulsa race massacre of 1921. My Favorite Murder is part of the Exactly Right podcast network that provides a platform for bold, creative voices to bring to life provocative, entertaining and relatable stories for audiences everywhere. The Exactly Right roster of podcasts covers a variety of topics including historic true crime, comedic interviews and news, science, pop culture and more. Podcasts on the network include Buried Bones with Kate Winkler Dawson and Paul Holes, That's Messed Up: An SVU Podcast, This Podcast Will Kill You, Bananas and more.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com